Interleukin (IL)-10 secreted by tumor-associated M2-like macrophages inhibits CD8+ T cell responses to chemotherapy by suppressing the inflammatory cytokine IL-12 from tumor-infiltrating DCs [29]. The gene discussed is CD8A; the disease is neoplasm.